These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

71 related items for PubMed ID: 2671856

  • 1. [Does the renal threshold change? Insulin therapy, based on urine glucose concentration, controlled by a dosage-measuring computer].
    Hermányi I, Deutsoh T, Tamás G.
    Orv Hetil; 1989 Jun 11; 130(24):1269-72. PubMed ID: 2671856
    [Abstract] [Full Text] [Related]

  • 2. Urine glucose testing: reliable backup for whole blood glucose monitoring.
    Kabadi UM.
    J Fam Pract; 1992 Apr 11; 34(4):495-7. PubMed ID: 1556542
    [Abstract] [Full Text] [Related]

  • 3. Glycaemic control with modified intensive insulin injections (MII) using insulin pens and premixed insulin in children with type-1 diabetes: a randomized controlled trial.
    Soliman AT, Omar M, Rizk MM, El Awwa A, AlGhobashy FM.
    J Trop Pediatr; 2006 Aug 11; 52(4):276-81. PubMed ID: 16410276
    [Abstract] [Full Text] [Related]

  • 4. Management of diabetics with the use of a microprocessor: comparison of insulin treatments based on blood and urine glucose levels.
    Hermányi I, Tamás G.
    Acta Diabetol Lat; 1988 Aug 11; 25(1):33-40. PubMed ID: 3043988
    [Abstract] [Full Text] [Related]

  • 5. [Improvement in the treatment of diabetes by means of a portable insulin-infusion apparatus. Preliminary results in 4 unstable juvenile diabetics].
    Porr O, Morell B, Walter H, Sturzenegger J, Froesch ER.
    Schweiz Med Wochenschr; 1980 Nov 22; 110(47):1761-3. PubMed ID: 7006076
    [Abstract] [Full Text] [Related]

  • 6. Is the frequency of self-monitoring of blood glucose related to long-term metabolic control? Multicenter analysis including 24,500 patients from 191 centers in Germany and Austria.
    Schütt M, Kern W, Krause U, Busch P, Dapp A, Grziwotz R, Mayer I, Rosenbauer J, Wagner C, Zimmermann A, Kerner W, Holl RW, DPV Initiative.
    Exp Clin Endocrinol Diabetes; 2006 Jul 22; 114(7):384-8. PubMed ID: 16915542
    [Abstract] [Full Text] [Related]

  • 7. [Metabolic self care in diabetics: when blood sugar analysis, when urine analysis?].
    Villiger U.
    Schweiz Med Wochenschr; 1986 Jan 18; 116(3):82-6. PubMed ID: 3945792
    [Abstract] [Full Text] [Related]

  • 8. On-line adaptive algorithm with glucose prediction capacity for subcutaneous closed loop control of glucose: evaluation under fasting conditions in patients with Type 1 diabetes.
    Schaller HC, Schaupp L, Bodenlenz M, Wilinska ME, Chassin LJ, Wach P, Vering T, Hovorka R, Pieber TR.
    Diabet Med; 2006 Jan 18; 23(1):90-3. PubMed ID: 16409572
    [Abstract] [Full Text] [Related]

  • 9. Controlled study on the use of hand-held insulin dosage computers enabling conversion to and optimizing of meal-related insulin therapy regimens.
    Schrezenmeir J, Achterberg H, Bergeler J, Küstner E, Stümer W, Hutten H, Beyer J.
    Life Support Syst; 1985 Jan 18; 3 Suppl 1():561-7. PubMed ID: 3916620
    [Abstract] [Full Text] [Related]

  • 10. In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine.
    Bruttomesso D, Crazzolara D, Maran A, Costa S, Dal Pos M, Girelli A, Lepore G, Aragona M, Iori E, Valentini U, Del Prato S, Tiengo A, Buhr A, Trevisan R, Baritussio A.
    Diabet Med; 2008 Mar 18; 25(3):326-32. PubMed ID: 18307459
    [Abstract] [Full Text] [Related]

  • 11. Increased renal glucose metabolism in Type 1 diabetes mellitus.
    Meyer C, Tolias A, Platanisiotis D, Stumvoll M, Vlachos L, Mitrakou A.
    Diabet Med; 2005 Apr 18; 22(4):453-9. PubMed ID: 15787672
    [Abstract] [Full Text] [Related]

  • 12. [Insulin Lispro (Lys B28, Pro B29) treatment in adolescents and young people with type 1 diabetes].
    Tuset Castellano MJ, Martínez Badás I, Alonso Blanco M, Barrio Castellanos R.
    An Esp Pediatr; 2000 Apr 18; 52(4):334-8. PubMed ID: 11003924
    [Abstract] [Full Text] [Related]

  • 13. Twice-daily compared with once-daily insulin glargine in people with Type 1 diabetes using meal-time insulin aspart.
    Ashwell SG, Gebbie J, Home PD.
    Diabet Med; 2006 Aug 18; 23(8):879-86. PubMed ID: 16911626
    [Abstract] [Full Text] [Related]

  • 14. Improved glycaemic control of thrice-daily biphasic insulin aspart compared with twice-daily biphasic human insulin; a randomized, open-label trial in patients with type 1 or type 2 diabetes.
    Clements MR, Tits J, Kinsley BT, Råstam J, Friberg HH, Ligthelm RJ.
    Diabetes Obes Metab; 2008 Mar 18; 10(3):229-37. PubMed ID: 18269638
    [Abstract] [Full Text] [Related]

  • 15. Efficacy comparison between preprandial and postprandial insulin aspart administration with dose adjustment for unpredictable meal size.
    Jovanovic L, Giammattei J, Acquistapace M, Bornstein K, Sommermann E, Pettitt DJ.
    Clin Ther; 2004 Sep 18; 26(9):1492-7. PubMed ID: 15531011
    [Abstract] [Full Text] [Related]

  • 16. Renal glucose excretion as a function of blood glucose concentration in subjects with type 2 diabetes--results of a hyperglycaemic glucose clamp study.
    Rave K, Nosek L, Posner J, Heise T, Roggen K, van Hoogdalem EJ.
    Nephrol Dial Transplant; 2006 Aug 18; 21(8):2166-71. PubMed ID: 16627603
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Effect of acarbose on postprandial increase in blood glucose. Additive acute effect of once daily administration in insulin treated diabetes].
    Ledermann H, Höxter G.
    Fortschr Med; 1994 Nov 20; 112(32):467-70. PubMed ID: 7821886
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.